cell_type

ASTROCYTE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ASTROCYTE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4754Connections

30Hypotheses

2Analyses

50Outgoing

50Incoming

20Experiments

9Debates

Summary

Astrocytes are the most abundant glial cells in the CNS, performing critical roles in blood-brain barrier maintenance, neurotransmitter recycling (glutamate uptake via GLT-1), metabolic support (astrocyte-neuron lactate shuttle), ion homeostasis (K+ buffering), and synapse formation/pruning. Astrocytes form the glymphatic system, a brain-wide waste clearance network that removes amyloid-beta and tau during sleep via AQP4 water channels. In neurodegeneration, astrocytes become reactive: A1 astrocytes (induced by microglia via TNF-alpha, IL-1alpha, C1q) are neurotoxic, while A2 astrocytes are neuroprotective. Reactive astrogliosis is a hallmark of AD, PD, ALS, and MS. Therapeutic targeting of astrocyte reactivity, glutamate transport, and glymphatic function are active research areas.

View on Wiki →

No AI portrait yet

🧫 Cell Type Info

Cell Type	ASTROCYTE
Definition	Astrocytes are star-shaped glial cells that provide metabolic and structural support to neurons, regulate neurotransmission, maintain the blood-brain barrier, and respond to neural injury.
Key Markers	GFAP, AQP4, ALDH1L1, S100B
Key Pathways	Apoptosis, Autophagy, Blood-Brain Barrier, Complement, Mtor
Associated Diseases	Aging, Als, Alzheimer, Cancer, Depression, Inflammation
Linked Hypotheses	603 hypotheses

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Astrocyte Reactivity Mechanism

mechanism · 4559 words

→

Pathway Diagram

graph TD
    ASTROCYTE["ASTROCYTE"]
    ASTROCYTE -->|"implicated in"| Alzheimer_s_disease["Alzheimer's disease"]
    ASTROCYTE -->|"interacts"| MICROGLIA["MICROGLIA"]
    ASTROCYTE -->|"expressed in"| C3["C3"]
    ASTROCYTE -->|"activates"| Neuroinflammation["Neuroinflammation"]
    ASTROCYTE -->|"causes"| Inflammation["Inflammation"]
    ASTROCYTE -->|"causes"| Multiple_Sclerosis["Multiple Sclerosis"]
    ASTROCYTE -->|"causes"| ALS["ALS"]
    ASTROCYTE -->|"causes"| Autoimmune["Autoimmune"]
    ASTROCYTE -->|"causes"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    BMAL1["BMAL1"] -->|"expressed in"| ASTROCYTE
    LC3B["LC3B"] -->|"expressed in"| ASTROCYTE
    MAP1LC3B["MAP1LC3B"] -->|"expressed in"| ASTROCYTE
    CB2R["CB2R"] -->|"expressed in"| ASTROCYTE
    APOE["APOE"] -->|"regulates"| ASTROCYTE
    NRF2["NRF2"] -->|"expressed in"| ASTROCYTE
    NOX4["NOX4"] -->|"expressed in"| ASTROCYTE
    STAT3["STAT3"] -->|"regulates"| ASTROCYTE

Outgoing (2317)

Target	Relation	Type	Str
Nf-Κb	activates	pathway	1.00
Neurodegeneration	regulates	disease	1.00
Aging	activates	disease	1.00
Alzheimer	activates	disease	1.00
Stroke	activates	disease	1.00
NEUROINFLAMMATION	activates	gene	1.00
Neurodegeneration	activates	disease	1.00
NEURON	activates	cell_type	1.00
MICROGLIA	activates	gene	1.00
Multiple sclerosis	associated_with	disease	1.00
Neuroinflammation	activates	disease	1.00
Inflammation	causes	disease	1.00
Als	activates	disease	1.00
Depression	activates	disease	1.00
Als	therapeutic_target	disease	1.00
Inflammation	activates	disease	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
Stem Cell	activates	pathway	1.00
Neurodegeneration	therapeutic_target	disease	1.00
Inflammation	regulates	disease	1.00
Cancer	activates	disease	1.00
DEPRESSION	activates	gene	1.00
Apoptosis	activates	pathway	1.00
Oxidative Stress	activates	pathway	1.00
AKT	activates	gene	1.00
Alzheimer	regulates	disease	0.95
Als	regulates	disease	0.95
Neuroinflammation	regulates	disease	0.95
Epilepsy	activates	disease	0.95
Neuroinflammation	causes	disease	0.95
Inflammation	therapeutic_target	disease	0.95
Als	expressed_in	disease	0.95
Neuroprotective Astrocyte Reactivity	involved_in	phenotype	0.95
Autoimmune	activates	disease	0.95
Anxiety	activates	disease	0.95
Alzheimer'S Disease	involved_in	disease	0.95
Neuroinflammation	therapeutic_target	disease	0.95
Neurodegeneration	causes	disease	0.95
Neurotoxic Astrocyte Reactivity	involved_in	phenotype	0.95
Glymphatic System	involved_in	process	0.95
Parkinson	activates	disease	0.95
blood-brain barrier	component_of	process	0.90
neurodegenerative stress response	involved_in	process	0.90
Microglia	interacts_with	cell_type	0.90
Active Lesion Rim	involved_in	phenotype	0.90
Chi3l1/YKL-40	regulates	protein	0.90
Synaptic Dysfunction	contributes_to	phenotype	0.90
Excitotoxicity	mediates	process	0.90
CHI3L1	product_of	protein	0.90
Neuroinflammation	mediates	process	0.90

Incoming (2437)

Source	Relation	Type	Str
ALZHEIMER	activates	gene	1.00
ASTROCYTES	activates	gene	1.00
NEURODEGENERATION	activates	gene	1.00
NF-ΚB	activates	gene	1.00
TNF-Α	activates	gene	1.00
GENES	activates	gene	1.00
NEURODEGENERATION	regulates	gene	1.00
ASTROCYTES	regulates	gene	1.00
ASTROCYTES	inhibits	gene	1.00
TNF	activates	gene	1.00
ASTROCYTES	associated_with	gene	1.00
ASTROCYTES	therapeutic_target	gene	1.00
CYTOKINES	activates	gene	1.00
INFLAMMATION	activates	gene	1.00
STAT3	activates	gene	1.00
ASTROCYTES	causes	gene	1.00
MYELIN	activates	gene	1.00
OXIDATIVE STRESS	activates	gene	1.00
APOPTOSIS	activates	gene	1.00
CANCER	activates	gene	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
necroptosis	causes	process	0.95
TNF	modulates	protein	0.90
COMPLEMENT CASCADE	causes	pathway	0.90
C3	secreted_by	protein	0.90
GJA1	expressed_in	protein	0.90
THYROID HORMONE	regulates	entity	0.90
biomarkers-astrocyte-exosomal-mrna-reference-genes	describes	wiki	0.90
LACCER	upregulated_in	compound	0.90
IL-6	promotes_apoptosis	protein	0.90
SNCA	activates	protein	0.90
BST2	expressed_in	gene	0.90
GFAP	expressed_in	gene	0.90
APOE4	disrupts	gene	0.90
CHI3L1	secreted_by	protein	0.90
SAPAP3	expressed_in	gene	0.90
PARKINSON'S DISEASE	activates	gene	0.90
EPILEPSY	activates	gene	0.90
ALS	activates	gene	0.90
ALZHEIMER	regulates	gene	0.90
ASTROCYTES	expressed_in	gene	0.90
PI3K	activates	gene	0.90
NEURODEGENERATION	causes	gene	0.90
ASTROCYTES	interacts_with	gene	0.90
PARKINSON	activates	gene	0.90
proinflammatory cytokines	modulates	pathway	0.87
MCT8	regulates	entity	0.85
TNBC	interacts_with	disease	0.85
reactive_astrocyte	associated_with	cell_type	0.80
IL1A	induces_a1_phenotype	protein	0.80

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener	0.892	neurodegeneration	Gene expression changes in aging mouse b
Beta-frequency entrainment therapy targeting PV interneuron-	0.884	alzheimers	Circuit-level neural dynamics in neurode
Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte	0.839	neurodegeneration	Which specific factors in conditioned me
AMPK hypersensitivity in astrocytes creates enhanced mitocho	0.833	neurodegeneration	Mitochondrial transfer between astrocyte
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S	0.822	neurodegeneration	What are the mechanisms by which gut mic

Selective LXRβ agonists restore ABCA1/ABCG1 expression and A	0.763	neuroscience	APOE4-driven lipid metabolism dysregulat
APOE4 astrocytes exhibit impaired cholesterol efflux via ABC	0.758	neuroscience	APOE4-driven lipid metabolism dysregulat
GFAP-Positive Reactive Astrocyte Subtype Delineation	0.754	alzheimers	SEA-AD Gene Expression Profiling — Allen
Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate	0.749	alzheimers-disease-parkinsons	-
Adenosine-Astrocyte Metabolic Reset	0.730	neurodegeneration	Sleep disruption as cause and consequenc
Astrocyte-Mediated Neuronal Epigenetic Rescue	0.725	neurodegeneration	Epigenetic reprogramming in aging neuron
Calcium-Dependent S100B Release from Astrocyte End-Feet as a	0.725	-	What blood-brain barrier permeability ch
Circadian Rhythm Entrainment of Reactive Astrocytes	0.722	neurodegeneration	Astrocyte reactivity subtypes in neurode
H3: APOE4 Impairs Cholesterol Trafficking, Triggering Astroc	0.720	neurodegeneration	Do APOE4-driven senescent astrocytes cau
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen	0.716	neurodegeneration	TREM2 in Alzheimer's Disease: Mechanisms
H4: Senomorphic Compounds Preserve Astrocyte Function While	0.710	neurodegeneration	Do APOE4-driven senescent astrocytes cau
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene	0.708	neurodegeneration	Gene expression changes in aging mouse b
CSF/Plasma AQP4 Polarization Index as a Novel Biomarker of A	0.705	-	What blood-brain barrier permeability ch
Astrocyte-Neuron Metabolic Coupling Titration	0.704	metabolic-neuroscience	What determines the optimal timing and d
Gamma entrainment restores astrocyte-neuron metabolic coupli	0.700	alzheimers	Gamma entrainment therapy to restore hip
Astrocyte-Neuron Metabolic Coupling Failure Precedes Neurode	0.690	neurodegeneration	Gap 006 analysis (archived stub)
Astrocyte Reactivity Heterogeneity with APOE4-Dependent Vuln	0.690	neurodegeneration	Cell type vulnerability debate in Alzhei
Blood Astrocyte-Derived Exosomal AQP4 Mislocalization Predic	0.685	-	What blood-brain barrier permeability ch
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles	0.682	neurodegeneration	Which cell types show the most significa
TREM2 R47H variant synergizes with APOE4 to collapse microgl	0.681	neuroscience	APOE4-driven lipid metabolism dysregulat
Astrocyte-Mediated Microglial Memory Erasure	0.677	-	Neuroinflammation and microglial priming
AQP4-Dependent Astrocyte Swelling Exacerbates Excitotoxic Ne	0.670	neurodegeneration	What are the specific molecular mechanis
Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli	0.668	alzheimers	Cell type vulnerability in Alzheimers Di
GFAP-Bearing Circulating Extracellular Vesicles Originating	0.665	-	What blood-brain barrier permeability ch
TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio	0.000	als	What are the mechanisms by which microgl

Mentioning Analyses (2)

Scientific analyses that reference this entity

What are the precise temporal dynamics of astrocyte ketone production decline du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.808

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

neurodegeneration | 2026-04-03 | 19 hypotheses Top: 0.891

Experiments (20)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
iPSC-derived astrocyte-neuron co-culture mitochondrial transfer in PD	exploratory	Parkinson's disease	0.900	0.00	iPSC-derived dopaminergic neur	proposed	N/A
iPSC-NPC effects on astrocytes in vitro ICH model	exploratory	intracerebral hemorrhage	0.900	0.00	in vitro ICH cell culture mode	completed	N/A
Cognitive impact of TDP-43 pathology in AD patients	clinical	Alzheimer's disease	0.700	0.00	human patients	completed	N/A
PINK1 mutation carriers frequently report experiencing pain.	genetic_association	Parkinson's disease	0.500	0.00	human	extracted	N/A
Evidence regarding pain in DNAJC6 pathogenic variants is limited and i	genetic_association	Parkinson's disease	0.500	0.00	human	extracted	N/A
Identification of a vulnerable subtype of dopaminergic neurons co-expr	genetic_association	Parkinson's disease	0.500	0.00	mouse	extracted	N/A
Evidence regarding pain in SYNJ1 pathogenic variants is limited and in	genetic_association	Parkinson's disease	0.500	0.00	human	extracted	N/A
Anxa1+ DANs show selective earlier loss compared to other dopaminergic	neuropathology	Parkinson's disease	0.500	0.00	mouse	extracted	N/A
Released prosaposin (PSAP) was shown to induce interleukin-6 (IL-6) up	cell_biology	Parkinson's disease	0.500	0.00	cell_culture	extracted	N/A
Evidence regarding pain in FBXO7 pathogenic variants is limited and in	genetic_association	Parkinson's disease	0.500	0.00	human	extracted	N/A
Evidence regarding pain in ATP13A2 pathogenic variants is limited and	genetic_association	Parkinson's disease	0.500	0.00	human	extracted	N/A
Inhibition of transmitter release specifically in Anxa1+ neurons was s	animal_model	Parkinson's disease	0.500	0.00	mouse	extracted	N/A
Identified a subtype of Sox6+ Anxa1+ dopaminergic neurons that are sel	neuropathology	Parkinson's disease	0.500	0.00	mouse	extracted	N/A
Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an	falsification	Neurodegeneration	0.400	0.50	cell_line	completed	$100,000
Metabolic Pathway-Targeted Therapy in ALS	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Animal Model Comparison for Neurodegenerative Disease Therapeutics	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,100,000
Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
Mechanism: Selective Vulnerability of Dopaminergic Neurons in Parkinso	validation	Parkinson's Disease	0.400	0.50	human	proposed	$3,000,000
Selective Vulnerability of Dopaminergic Neurons — Mechanism and Protec	validation	Neurodegeneration	0.400	0.50	cell_line	proposed	$160,000
GLP-1 Agonist Neuroprotection Mechanism in PD	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Recept [PMID:28709002]	Nabet BY, Qiu Y, Shabason JE, Wu TJ, Yoo	Cell	2017	412
Transcriptomic cytoarchitecture reveals principles of human neocortex organizati [PMID:37824655]	Jorstad NL, Close J, Johansen N, Yanny A	Science	2023	186
Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosi [PMID:38642614]	Han QQ, Shen SY, Liang LF, Chen XR, Yu J	Brain Behav Immun	2024	1
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704]	Zhang T, Xu D, Trefts E, Lv M, Inuzuka H	Science	2023	1
A lineage-resolved molecular atlas of C. elegans embryogenesis at single-cell re [PMID:31488706]	Packer JS, Zhu Q, Huynh C, Sivaramakrish	Science	2019	1
Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892]	Wang Y, An H, Liu T, Qin C, Sesaki H, Gu	Cell Rep	2019	1
Metabolic asymmetry and the global diversity of marine predators. [PMID:30679341]	Grady JM, Maitner BS, Winter AS, Kaschne	Science	2019	1
AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310]	Song X, Zhu S, Chen P, Hou W, Wen Q, Liu	Curr Biol	2018	1
A Never-Ending Story of Per- and Polyfluoroalkyl Substances (PFASs)? [PMID:28224793]	Wang Z, DeWitt JC, Higgins CP, Cousins I	Environ Sci Technol	2017	1
Gene Expression by Mouse Inner Ear Hair Cells during Development. [PMID:25904789]	Scheffer DI, Shen J, Corey DP, Chen ZY	J Neurosci	2015	1
Mitochondrial dysfunction and Parkinson disease: a Parkin-AMPK alliance in neuro [PMID:26121488]	Hang L, Thundyil J, Lim KL	Ann N Y Acad Sci	2015	1
Chapter 6: Structural variation and medical genomics. [PMID:23300412]	Raphael BJ	PLoS Comput Biol	2012	1
Caffeine and adenosine. [PMID:20164566]	Ribeiro JA, Sebastião AM	J Alzheimers Dis	2010	1
Independent and interactive contributions of white matter hyperintensities and A [PMID:41906163]	Dario Bachmann; Christoph Gericke; Maha	Alzheimer's research & the	2026	0
Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associate [PMID:41905188]	Cetindag AC, Schipke CG, Esselmann H, Kr	The journal of prevention of A	2026	0
AMPKα1 Deficiency in Macrophages Impairs Tendon Regeneration and Tendon Stem Cel [PMID:41694579]	Zhu L, Wang Y, Shi X, Yu M, Cai X, Chen	International journal of biolo	2026	0
Single-cell transcriptome analysis reveals a cellular immune response in common [PMID:41692207]	Shi X, Ji G, Liu D, Zhao T, Tian S, Li S	International journal of biolo	2026	0
Farrerol ameliorates hepatic insulin resistance via AMPKα1/mTOR/SREBP-1 pathway: [PMID:41702183]	Li Y, Feng X, Zheng L	Tissue & cell	2026	0
Biomarkers for Alzheimer's disease across diverse biological domains: an umbrell [PMID:40680830]	Kang J, Son Y, Yim Y, Cho H, Kim J et al	J Adv Res	2026	0
Potential diagnostic markers in Alzheimer's disease: current perspectives and fu [PMID:40911035]	Zheng M, Wang S, Jia J	Neurodegener Dis Manag	2026	0

Debates (9)

Multi-agent debates referencing this entity

Second debate: Microglial TREM2-SYK Pathway Enhancement

closed · Rounds: 4 · Score: 0.57 · 2026-04-28

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

closed · Rounds: 4 · Score: 0.12 · 2026-04-27

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

closed · Rounds: 4 · Score: 0.42 · 2026-04-27

Debate: LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability i

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes

closed · Rounds: 4 · Score: 0.47 · 2026-04-27

Should '40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Sele

closed · Rounds: 4 · Score: 0.52 · 2026-04-27

Should 'ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matt

closed · Rounds: 4 · Score: 0.72 · 2026-04-27

The debate identified a critical therapeutic window when astrocytic ketone produ

closed · Rounds: 4 · Score: 0.85 · 2026-04-15

What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transc

closed · Rounds: 4 · Score: 0.90 · 2026-04-03

Related Research

Hypotheses and analyses mentioning ASTROCYTE in their description or question text

ASTROCYTE

Understanding Entity Pages

Summary

Wiki Pages (1)

Astrocyte Reactivity Mechanism

Pathway Diagram

Outgoing (2317)

Incoming (2437)

Targeting Hypotheses (30)

Mentioning Analyses (2)

What are the precise temporal dynamics of astrocyte ketone production decline du

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

Experiments (20)

Related Papers (20)

Debates (9)

Second debate: Microglial TREM2-SYK Pathway Enhancement

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

Debate: LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability i

Debate: ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes

Should '40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Sele

Should 'ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matt

The debate identified a critical therapeutic window when astrocytic ketone produ

What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transc

Related Research

Selective LXRβ agonists restore ABCA1/ABCG1 expression and APOE lipidation in AP

APOE4 astrocytes exhibit impaired cholesterol efflux via ABCA1/ABCG1 transporter

GFAP-Positive Reactive Astrocyte Subtype Delineation

Adenosine-Astrocyte Metabolic Reset

Astrocyte-Mediated Neuronal Epigenetic Rescue

Calcium-Dependent S100B Release from Astrocyte End-Feet as an Early Signal of As

Circadian Rhythm Entrainment of Reactive Astrocytes

H3: APOE4 Impairs Cholesterol Trafficking, Triggering Astrocyte Senescence

TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration

H4: Senomorphic Compounds Preserve Astrocyte Function While Reversing Senescence

TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegeneration

CSF/Plasma AQP4 Polarization Index as a Novel Biomarker of Astrocyte Glymphatic

Astrocyte-Neuron Metabolic Coupling Titration

Gamma entrainment restores astrocyte-neuron metabolic coupling through Cx43 hemi